Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedCAC Supports Some PGx Test Regimens, But Calls For Overall Better Data

This article was originally published in The Gray Sheet

Executive Summary

There is enough strong evidence to show that a select few pharmacogenomic (PGx) tests can be applied in a manner that positively affects patient outcomes, members of a CMS advisory panel concluded Jan. 27

You may also be interested in...



CMS Director To Diagnostics Industry: Prove Your Cancer Tests Work

“Why are insurers so reluctant to get enthusiastic and really embrace molecular diagnostics?” asked the director of CMS’ coverage and analysis group at a recent cancer diagnostics symposium. “Because half the time we have no idea what on earth we’re paying for.”

CMS Will Weigh Three New Tech Assessments On Genetic Testing For Cancer

Two of the assessments are intended to inform an upcoming Medicare Evidence Development and Coverage Advisory Committee meeting.

CMS Will Weigh Three New Tech Assessments On Genetic Testing For Cancer

Two of the assessments are intended to inform an upcoming Medicare Evidence Development and Coverage Advisory Committee meeting.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel